Eileen Sheil - Cue Health Chief Officer
| HLTH Stock | USD 0.14 0.01 6.67% |
Insider
Eileen Sheil is Chief Officer of Cue Health
| Address | 4980 Carroll Canyon Road, San Diego, CA, United States, 92121 |
| Phone | 858 412 8151 |
| Web | https://www.cuehealth.com |
Cue Health Management Efficiency
The company has return on total asset (ROA) of (0.3188) % which means that it has lost $0.3188 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9035) %, meaning that it created substantial loss on money invested by shareholders. Cue Health's management efficiency ratios could be used to measure how well Cue Health manages its routine affairs as well as how well it operates its assets and liabilities. The Cue Health's current Return On Tangible Assets is estimated to increase to -1.11. The current Return On Capital Employed is estimated to decrease to -1.05. As of now, Cue Health's Intangibles To Total Assets are increasing as compared to previous years. The Cue Health's current Fixed Asset Turnover is estimated to increase to 0.86, while Non Current Assets Total are projected to decrease to under 212.8 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Giuseppe Ciaramella | Beam TherapeuticsInc | 55 | |
| Michael Bell | Guardant Health | 55 | |
| Beverly CPA | Veracyte | 61 | |
| Erin Smith | Twist Bioscience Corp | N/A | |
| Alexis Komor | Beam TherapeuticsInc | N/A | |
| Nicole Gaudelli | Beam TherapeuticsInc | N/A | |
| Andy Ament | Guardant Health | N/A | |
| YuWaye MD | Fate Therapeutics | N/A | |
| Aaron Sato | Twist Bioscience Corp | N/A | |
| TerryAnn MBA | Beam TherapeuticsInc | 47 | |
| David Liu | Beam TherapeuticsInc | N/A | |
| Marc Stapley | Veracyte | 54 | |
| MS MBA | Fate Therapeutics | N/A | |
| Craig MD | Guardant Health | 57 | |
| Jonathan Wygant | Veracyte | 53 | |
| Tracy Morris | Veracyte | N/A | |
| Kevin Yankton | Twist Bioscience Corp | 57 | |
| Brian Riley | Beam TherapeuticsInc | 47 | |
| Kumud Kalia | Guardant Health | 58 | |
| Mark DVM | Fate Therapeutics | 63 | |
| Suzanne Fleming | Beam TherapeuticsInc | 63 | |
Management Performance
| Return On Equity | -0.9 | ||||
| Return On Asset | -0.32 |
Cue Health Leadership Team
Elected by the shareholders, the Cue Health's board of directors comprises two types of representatives: Cue Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cue. The board's role is to monitor Cue Health's management team and ensure that shareholders' interests are well served. Cue Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cue Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Steve Ozonian, Chairman of the Board | ||
| Harry Fleming, CEO, Director, Chairman of Acquisition Committee and Chairman of Strategy Committee | ||
| Phil Ayres, Chief Marketing Officer | ||
| Nitin Duggal, Chief Officer | ||
| Thomas Foster, Director | ||
| James Springfield, CEO | ||
| John Gallagher, Chief Officer | ||
| Marcos Rodriguez, Chief Accounting Officer | ||
| Kenneth Efird, President | ||
| Clint Sever, CoFounder Officer | ||
| Donald Kramer, Director | ||
| Randall Pollard, Controller Officer | ||
| Christopher Achar, Chief Director | ||
| Suzanne Stone, Chief Officer | ||
| Erica Esq, General Secretary | ||
| Lorna Williams, Vice Relations | ||
| Kenneth Klein, CFO | ||
| Allison Blackwell, Chief Officer | ||
| David Arida, Chief Officer | ||
| Ayub Khattak, President, CoFounder | ||
| Brandon Moreno, CFO | ||
| Kenny Klein, CFO, Chief Accounting Officer | ||
| Dena Cook, Chief Officer | ||
| Jennifer Pfahler, Independent Director | ||
| David Young, CFO | ||
| Aasim Javed, Treasurer CFO | ||
| Richard Ganley, Independent Director | ||
| Eileen Sheil, Chief Officer | ||
| Michael Nichols, Director | ||
| Susan Watt, Director | ||
| Neil Badlani, Director | ||
| Steven Ozonian, Chairman of the Board | ||
| David MD, Chief Officer |
Cue Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cue Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.9 | ||||
| Return On Asset | -0.32 | ||||
| Operating Margin | (2.83) % | ||||
| Current Valuation | (10.6 M) | ||||
| Shares Outstanding | 159.09 M | ||||
| Shares Owned By Insiders | 12.78 % | ||||
| Shares Owned By Institutions | 47.72 % | ||||
| Number Of Shares Shorted | 571.42 K | ||||
| Price To Earning | 16.86 X | ||||
| Price To Book | 0.10 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cue Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cue Health's short interest history, or implied volatility extrapolated from Cue Health options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Cue Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Cue Stock please use our How to Invest in Cue Health guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for Cue Stock analysis
When running Cue Health's price analysis, check to measure Cue Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cue Health is operating at the current time. Most of Cue Health's value examination focuses on studying past and present price action to predict the probability of Cue Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cue Health's price. Additionally, you may evaluate how the addition of Cue Health to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is Cue Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cue Health. If investors know Cue will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cue Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Earnings Share (2.44) | Revenue Per Share 0.464 | Quarterly Revenue Growth (0.87) | Return On Assets (0.32) |
The market value of Cue Health is measured differently than its book value, which is the value of Cue that is recorded on the company's balance sheet. Investors also form their own opinion of Cue Health's value that differs from its market value or its book value, called intrinsic value, which is Cue Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cue Health's market value can be influenced by many factors that don't directly affect Cue Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cue Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cue Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cue Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.